Progress in Pediatric Cardiology
Volume 25, Issue 1 , Pages 27-29 , April 2008

Clinical issues in the pediatric hypertrophic cardiomyopathies

References 

  1. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816
  2. Colan SD. Classification of the cardiomyopathies. Prog Pediatr Cardiol. 2007;23:5–15
  3. Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007;115:773–781
  4. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109:2807–2816
  5. Taylor MR, Carniel E, Mestroni L. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing. Expert Rev Mol Diagn. 2004;4:99–113
  6. Van Driest SL, Will ML, Atkins DL, Ackerman MJ. A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood. Am J Cardiol. 2002;90:1123–1127
  7. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy — distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227–2232
  8. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death — revisited in a large non-referral-based patient population. Circulation. 2000;102:858–864
  9. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005;80:463–469
  10. Ackerman MJ, Van Driest SL, Bos M. Are longitudinal, natural history studies the next step in genotype–phenotype translational genomics in hypertrophic cardiomyopathy?. J Am Coll Cardiol. 2005;46:1744–1746
  11. Lipshultz SE, Colan SD. Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol. 2004;22:769–773
  12. Silber JH, Cnaan A, Clark BJ, et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol. 2004;22:820–828

☆ Supported by NIH NHLBI grant RO1 HL53392 and the Children's Cardiomyopathy Foundation, Inc.

PII: S1058-9813(07)00164-6

doi: 10.1016/j.ppedcard.2007.11.004

Progress in Pediatric Cardiology
Volume 25, Issue 1 , Pages 27-29 , April 2008

Article Tools